During the SOFCEP-FILLTOX congress in Monaco, SYMATESE is proud to introduce its innovative range of HA*-based injectables to the French market. Developed with our COLD-X TECHNOLOGY®, these injectable gels provide long-lasting, natural-looking results with an excellent safety profile confirmed by robust clinical studies across Europe, the US, and China.
This milestone not only marks our entry into the French aesthetics market but also reinforces our global strategy, following a successful US launch and upcoming expansions into Europe, China, and Brazil.
With over 25 years of expertise in tissue regeneration and aesthetic medicine, SYMATESE continues to shape the future of medical innovation.
*Hyaluronic Acid
